Home › Cirrhosis › Maryland › Baltimore
Cirrhosis clinical trials in Baltimore, MD
4 studies for Cirrhosis are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
RecruitingPhase 3
- Mercy Medical Center, Baltimore
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RecruitingPhase 2
- Johns Hopkins Hospital, Baltimore
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RecruitingObservational study
- University of Maryland School of Medicine, Baltimore
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RecruitingPhase 4
- Mercy Medical Center, Baltimore
About Cirrhosis
Cirrhosis is caused when scar tissue replaces healthy tissue in the liver because of chronic injury. Learn how cirrhosis is diagnosed and treated.
More about Cirrhosis on MedlinePlus
Cirrhosis trials in other cities
- Boston, MA10 studies
- Cleveland, OH9 studies
- Dallas, TX8 studies
- Houston, TX7 studies
- San Antonio, TX6 studies
- Los Angeles, CA6 studies
- Miami, FL5 studies
- New York City, NY5 studies
- San Diego, CA4 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Chicago, IL4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.